Everolimus: In Patients with Subependymal Giant Cell Astrocytoma Associated with Tuberous Sclerosis Complex

ISSN： 1174-5878

Source： Pediatric Drugs, Vol.14, Iss.1, 2012-02, pp. : 51-60

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Everolimus tablets for patients with subependymal giant cell astrocytoma

By Turner Scott G Peters Katherine B Vredenburgh James J Desjardins Annick Friedman Henry S Reardon David A

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 14, 2011-10 ,pp. : 2265-2269

Informa Healthcare

Access to resources Recommend Favorite

Current Management of Tuberous Sclerosis Complex

By Krueger Darcy A. Franz David N.

Pediatric Drugs, Vol. 10, Iss. 5, 2008-01 ,pp. : 299-313

Adis International

Access to resources Recommend Favorite

Current Use of mTOR Inhibitors for the Treatment of Subependymal Giant Cell Astrocytomas and Epilepsy in Patients with TSC

Current Medicinal Chemistry, Vol. 23, Iss. 37, 2016-12 ,pp. : 4260-4269

Bentham Science Publishers

Access to resources Recommend Favorite

mTOR Inhibitors in Tuberous Sclerosis Complex

Current Neuropharmacology, Vol. 10, Iss. 4, 2012-12 ,pp. : 404-415

Bentham Science Publishers

Access to resources Recommend Favorite

Oral contraceptives: Angiomyolipoma in an adolescent patient with tuberous sclerosis complex: case report

Reactions Weekly, Vol. 1, Iss. 1125, 2006-01 ,pp. : 13-13

Adis International

Access to resources Recommend Favorite